Tower Research Capital (TRC)’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $18.2K | Buy |
2,183
+2,057
| +1,633% | +$14.9K | ﹤0.01% | 3847 |
|
|
2026
Q2 | $721 | Sell |
126
-1,703
| -93% | -$9.8K | ﹤0.01% | 4962 |
|
|
2026
Q1 | $11.5K | Sell |
1,829
-318
| -15% | -$2.95K | ﹤0.01% | 3838 |
|
|
2025
Q4 | $26.3K | Buy |
2,147
+1,156
| +117% | +$18.9K | ﹤0.01% | 2896 |
|
|
2025
Q3 | $20.3K | Sell |
991
-1,737
| -64% | -$27.6K | ﹤0.01% | 3294 |
|
|
2025
Q2 | $36.8K | Buy |
2,728
+1,515
| +125% | +$16.6K | ﹤0.01% | 3230 |
|
|
2025
Q1 | $10.5K | Sell |
1,213
-688
| -36% | -$4.2K | ﹤0.01% | 3632 |
|
|
2024
Q4 | $9.24K | Buy |
1,901
+964
| +103% | +$5.39K | ﹤0.01% | 3922 |
|
|
2024
Q3 | $7.23K | Sell |
937
-10,788
| -92% | -$95.9K | ﹤0.01% | 4064 |
|
|
2024
Q2 | $117K | Buy |
11,725
+11,223
| +2,236% | +$123K | ﹤0.01% | 2462 |
|
|
2024
Q1 | $6.1K | Sell |
502
-6,263
| -93% | -$90.8K | ﹤0.01% | 4433 |
|
|
2023
Q4 | $96.8K | Buy |
6,765
+5,432
| +408% | +$52.1K | ﹤0.01% | 2664 |
|
|
2023
Q3 | $10.4K | Buy |
1,333
+659
| +98% | +$7.17K | ﹤0.01% | 4117 |
|
|
2023
Q2 | $9.6K | Buy |
674
+59
| +10% | +$840 | ﹤0.01% | 4246 |
|
|
2023
Q1 | $9K | Sell |
615
-20,017
| -97% | -$335K | ﹤0.01% | 4522 |
|
|
2022
Q4 | $347K | Buy |
20,632
+19,364
| +1,527% | +$335K | 0.01% | 925 |
|
|
2022
Q3 | $19K | Sell |
1,268
-5,347
| -81% | -$106K | ﹤0.01% | 3981 |
|
|
2022
Q2 | $181K | Buy |
6,615
+6,137
| +1,284% | +$182K | ﹤0.01% | 1840 |
|
|
2022
Q1 | $18K | Buy |
478
+75
| +19% | +$3.32K | ﹤0.01% | 3640 |
|
|
2021
Q4 | $25K | Sell |
403
-540
| -57% | -$40.9K | ﹤0.01% | 3430 |
|
|
2021
Q3 | $81K | Buy |
943
+350
| +59% | +$22K | ﹤0.01% | 2578 |
|
|
2021
Q2 | $37K | Sell |
593
-478
| -45% | -$24.3K | ﹤0.01% | 3282 |
|
|
2021
Q1 | $52K | Sell |
1,071
-3,146
| -75% | -$152K | ﹤0.01% | 3091 |
|
|
2020
Q4 | $131K | Sell |
4,217
-11,376
| -73% | -$279K | ﹤0.01% | 2102 |
|
|
2020
Q3 | $325K | Buy |
15,593
+12,613
| +423% | +$217K | ﹤0.01% | 2113 |
|
|
2020
Q2 | $39K | Buy |
2,980
+2,730
| +1,092% | +$29.7K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $2K | Buy |
250
+149
| +148% | +$1.41K | ﹤0.01% | 2613 |
|
|
2019
Q4 | $1K | Sell |
101
-992
| -91% | -$11.2K | ﹤0.01% | 3299 |
|
|
2019
Q3 | $16K | Buy |
1,093
+892
| +444% | +$13.8K | ﹤0.01% | 2623 |
|
|
2019
Q2 | $3K | Sell |
201
-71
| -26% | -$959 | ﹤0.01% | 3154 |
|
|
2019
Q1 | $3K | Sell |
272
-4,576
| -94% | -$59.5K | ﹤0.01% | 3308 |
|
|
2018
Q4 | $53K | Buy |
4,848
+3,731
| +334% | +$55.2K | ﹤0.01% | 1253 |
|
|
2018
Q3 | $20K | Buy |
+1,117
| New | +$14.1K | ﹤0.01% | 2347 |
|
Other funds holding OPRX
MBAM
Tower Research Capital (TRC)'s OPRX Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its OptimizeRx (OPRX) stake by 1,633% in Q3 2026, buying an estimated $14.9K and bringing the position to 2,183 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.
Tower Research Capital (TRC) first reported a position in OPRX in Q3 2018 and has held it in 33 quarters since. The position peaked at $347K in Q4 2022. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.
- Tower Research Capital (TRC) held 2,183 shares of OptimizeRx worth $18.2K as of Q3 2026.
- Tower Research Capital (TRC) bought 2,057 OptimizeRx shares in Q3 2026, an estimated $14.9K.
- OptimizeRx made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3847 holding.
- Tower Research Capital (TRC) first reported a position in OptimizeRx in Q3 2018 and has held it in 33 quarters since.
- Tower Research Capital (TRC)'s OptimizeRx position peaked at $347K in Q4 2022.
- 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.